Largest pharmaceutical companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Viatris has the lowest figure of the 61 pharmaceutical companies ranked by earnings, at -SGD 4.5B, followed by Insmed (-SGD 1.6B) and Summit Therapeutics (-SGD 1.4B). Figures as of 18 Nov 2026, 19:33 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- Viatris-SGD 4.5B
- Median
- SGD 76.1M
- Combined market value
- SGD 6.53T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ViatrisVTRS · Health Care | -SGD 4.5B | SGD 30.4B | SGD 26.55 | 0.66% up | 96% up | ||
| 2 | InsmedINSM · Health Care | -SGD 1.6B | SGD 34B | SGD 154.97 | 1.41% down | 40% down | ||
| 3 | Summit TherapeuticsSMMT · Health Care | -SGD 1.4B | SGD 10.9B | SGD 13.64 | 0.89% down | 36% down | ||
| 4 | Takeda PharmaceuticalTAK · Health Care | -SGD 1.2B | SGD 87.7B | SGD 27.45 | 1.66% down | 54% up | ||
| 5 | CytokineticsCYTK · Health Care | -SGD 1B | SGD 9.2B | SGD 66.01 | 0.93% down | 20% down | ||
| 6 | BridgeBio PharmaBBIO · Health Care | -SGD 945.4M | SGD 19.5B | SGD 100.22 | 1.16% up | 17% up | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | -SGD 492M | SGD 5.9B | SGD 35.66 | 2.54% up | 64% down | ||
| 8 | ABIVAXABVX · Health Care | -SGD 481M | SGD 9.4B | SGD 107.74 | 1.73% up | 27% down | ||
| 9 | Jazz PharmaceuticalsJAZZ · Health Care | -SGD 459.4M | SGD 20.3B | SGD 317.02 | 2.10% up | 37% up | ||
| 10 | Cogent BiosciencesCOGT · Health Care | -SGD 424.3M | SGD 6.3B | SGD 36.23 | 0.86% up | 20% down | ||
| 11 | Praxis Precision MedicinesPRAX · Health Care | -SGD 391.2M | SGD 11.1B | SGD 395.46 | 0.50% up | 61% up | ||
| 12 | Roivant SciencesROIV · Health Care | -SGD 386.7M | SGD 35.9B | SGD 49.56 | 0.75% down | 90% up | ||
| 13 | Legend BiotechLEGN · Health Care | -SGD 382.9M | SGD 4B | SGD 20.85 | 0.31% up | 42% down | ||
| 14 | Madrigal PharmaceuticalsMDGL · Health Care | -SGD 371.9M | SGD 12B | SGD 518.16 | 4.81% down | 24% down | ||
| 15 | Ascendis PharmaASND · Health Care | -SGD 326.4M | SGD 22.8B | SGD 347.92 | 0.54% down | 28% up | ||
| 16 | Elanco Animal HealthELAN · Health Care | -SGD 299.3M | SGD 17.3B | SGD 34.63 | 3.87% up | 20% up | ||
| 17 | Rhythm PharmaceuticalsRYTM · Health Care | -SGD 253.5M | SGD 10.7B | SGD 154.92 | 2.99% up | 13% up | ||
| 18 | Definium TherapeuticsDFTX · Health Care | -SGD 237.1M | SGD 5B | SGD 36.88 | 2.69% down | 169% up | ||
| 19 | Axsome TherapeuticsAXSM · Health Care | -SGD 236.3M | SGD 9.1B | SGD 173.12 | 1.28% down | 7% down | ||
| 20 | Edgewise TherapeuticsEWTX · Health Care | -SGD 216.4M | SGD 5.9B | SGD 53.62 | 1.12% down | 88% up | ||
| 21 | Dianthus TherapeuticsDNTH · Health Care | -SGD 209.4M | SGD 6.2B | SGD 110.41 | 1.60% down | 113% up | ||
| 22 | Spyre TherapeuticsSYRE · Health Care | -SGD 200.2M | SGD 12.2B | SGD 128.27 | 6.00% up | 286% up | ||
| 23 | Protagonist TherapeuticsPTGX · Health Care | -SGD 167.9M | SGD 10.6B | SGD 161.84 | 0.63% up | 46% up | ||
| 24 | ErascaERAS · Health Care | -SGD 160.7M | SGD 6.1B | SGD 17.37 | 3.08% down | 403% up | ||
| 25 | Oruka TherapeuticsORKA · Health Care | -SGD 136M | SGD 8.3B | SGD 122.94 | 1.05% down | 241% up | ||
| 26 | Belite BioBLTE · Health Care | -SGD 100.1M | SGD 8.2B | SGD 202.14 | 0.64% down | 31% up | ||
| 27 | VeradermicsMANE · Health Care | -SGD 90.3M | SGD 6.8B | SGD 160.30 | 1.09% down | 233% up | ||
| 28 | Travere TherapeuticsTVTX · Health Care | -SGD 33M | SGD 6.3B | SGD 65.15 | 1.16% down | 44% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | -SGD 30.1M | SGD 7.8B | SGD 118.87 | 0.22% up | 31% up | ||
| 30 | Arrowhead PharmaceuticalsARWR · Health Care | -SGD 2.1M | SGD 7.9B | SGD 55.74 | 0.52% up | 10% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SGD 76.1M | SGD 9.6B | SGD 122.33 | 0.29% down | 126% up | ||
| 32 | Amneal PharmaceuticalsAMRX · Health Care | SGD 92.9M | SGD 9.8B | SGD 28.13 | 3.27% up | 83% up | ||
| 33 | Corcept TherapeuticsCORT · Health Care | SGD 128.5M | SGD 9.6B | SGD 87.31 | 3.41% down | 8% down | ||
| 34 | Ligand PharmaceuticalsLGND · Health Care | SGD 160.5M | SGD 7.7B | SGD 386.04 | 1.86% up | 43% up | ||
| 35 | AlkermesALKS · Health Care | SGD 311.7M | SGD 10.1B | SGD 59.83 | 2.05% up | 58% up | ||
| 36 | BeOne MedicinesONC · Health Care | SGD 370.1M | SGD 59.5B | SGD 521.33 | 2.20% down | 17% up | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | SGD 404.7M | SGD 25.8B | SGD 192.61 | 4.59% down | 66% down | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | SGD 450.1M | SGD 15.2B | SGD 78.60 | 4.14% up | 11% up | ||
| 39 | GrifolsGRFS · Health Care | SGD 575.3M | SGD 7.4B | SGD 10.86 | 2.42% down | 1% up | ||
| 40 | TG TherapeuticsTGTX · Health Care | SGD 576.8M | SGD 12.8B | SGD 84.70 | 4.71% up | 107% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | SGD 588.2M | SGD 16.1B | SGD 19.33 | 1.32% up | 5% up | ||
| 42 | PTC TherapeuticsPTCT · Health Care | SGD 880.6M | SGD 6.5B | SGD 77.40 | 0.60% down | 20% down | ||
| 43 | Royalty PharmaRPRX · Health Care | SGD 994.5M | SGD 51.4B | SGD 89.45 | 0.97% up | 78% up | ||
| 44 | GenmabGMAB · Health Care | SGD 1.2B | SGD 40.8B | SGD 66.16 | 1.29% down | 70% up | ||
| 45 | United TherapeuticsUTHR · Health Care | SGD 1.7B | SGD 31.8B | SGD 746.76 | 0.89% down | 23% up | ||
| 46 | Teva Pharmaceutical IndustriesTEVA · Health Care | SGD 1.8B | SGD 63.4B | SGD 54.35 | 1.15% down | 74% up | ||
| 47 | ZoetisZTS · Health Care | SGD 3.4B | SGD 44.7B | SGD 110.13 | 2.27% up | 29% down | ||
| 48 | Vertex PharmaceuticalsVRTX · Health Care | SGD 5.1B | SGD 175.8B | SGD 693.38 | 0.62% up | 27% up | ||
| 49 | AbbVieABBV · Health Care | SGD 5.5B | SGD 651.1B | SGD 368.37 | 2.47% down | 26% up | ||
| 50 | Regeneron PharmaceuticalsREGN · Health Care | SGD 5.8B | SGD 126.1B | SGD 1,218.67 | 1.36% down | 36% up | ||
| 51 | Abbott LaboratoriesABT · Health Care | SGD 8.4B | SGD 233.5B | SGD 134.81 | 0.19% down | 17% down | ||
| 52 | Bristol-Myers SquibbBMY · Health Care | SGD 9.1B | SGD 157.1B | SGD 76.87 | 2.87% down | 34% up | ||
| 53 | GSKGSK · Health Care | SGD 9.8B | SGD 125.7B | SGD 62.70 | 1.29% down | 6% up | ||
| 54 | PfizerPFE · Health Care | SGD 10B | SGD 206.2B | SGD 36.17 | 1.50% down | 14% up | ||
| 55 | SanofiSNY · Health Care | SGD 11.2B | SGD 146.2B | SGD 60.88 | 0.70% down | 4% down | ||
| 56 | AstraZenecaAZN · Health Care | SGD 13.2B | SGD 357.1B | SGD 230.28 | 2.06% down | 2% up | ||
| 57 | NovartisNVS · Health Care | SGD 18B | SGD 377.8B | SGD 200.04 | 2.55% down | 25% up | ||
| 58 | Novo NordiskNVO · Health Care | SGD 19.6B | SGD 224B | SGD 50.83 | 3.18% down | 17% down | ||
| 59 | Merck & CoMRK · Health Care | SGD 23.5B | SGD 436.7B | SGD 177.13 | 4.22% down | 51% up | ||
| 60 | Eli LillyLLY · Health Care | SGD 26.6B | SGD 1.59T | SGD 1,784.76 | 2.26% down | 35% up | ||
| 61 | Johnson & JohnsonJNJ · Health Care | SGD 34.6B | SGD 849.4B | SGD 352.84 | 1.86% down | 38% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2899 SGD).
Questions and answers
Which pharmaceutical companies have the lowest earnings?
Viatris (-SGD 4.5B), Insmed (-SGD 1.6B) and Summit Therapeutics (-SGD 1.4B) have the lowest earnings of the 61 pharmaceutical companies ranked here as of 18 Nov 2026, 19:33 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by earnings.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by earnings have a combined market value of SGD 6.53T as of 18 Nov 2026, 19:33 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.